EpiSign™ is the first-ever clinically validated test that analyzes genomic DNA methylation using cutting-edge artificial intelligence technologies to diagnose patients with rare diseases.
EpiSign™ uses machine learning-based algorithms to discover and identify DNA methylation patterns, or episignatures, associated with specific rare diseases including genetic and environmental exposure disorders. These episignatures are stored in the EpiSign™ Knowledge Database, the world’s largest epigenetic database for rare diseases.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 100 Collip Circle, Suite 120,office 1,canada
- Industry
- Health And Human Services
- NAICS
-
Administration of Human Resource ProgramsAdministration of Veterans' Affairs
- Website
- https://episign.com
- HQ
- London, Ontario
Episign Inc Questions
Episign Inc's website is https://episign.com
Episign Inc's LinkedIn profile is https://ca.linkedin.com/company/episign-inc
Episign Inc has
6 employees.
View email and phone details for 6
employees at Episign Inc.
Episign Inc's industry is
Health and Human Services
Episign Inc's categories are Health and Human Services
Episign Inc's founding year is 2022
